Harvard Bioscience, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HBIO research report →
Companywww.harvardbioscience.com
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments.
- CEO
- John Duke
- IPO
- 2001
- Employees
- 330
- HQ
- Holliston, MA, US
Price Chart
Valuation
- Market Cap
- $24.35M
- P/E
- -2.47
- P/S
- 0.28
- P/B
- 2.40
- EV/EBITDA
- 36.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 57.06%
- Op Margin
- 1.39%
- Net Margin
- -11.44%
- ROE
- -73.04%
- ROIC
- 2.11%
Growth & Income
- Revenue
- $86.55M · -8.06%
- Net Income
- $-56,700,000 · -357.07%
- EPS
- $-12.80 · -357.14%
- Op Income
- $-629,000
- FCF YoY
- 408.01%
Performance & Tape
- 52W High
- $9.50
- 52W Low
- $2.80
- 50D MA
- $5.66
- 200D MA
- $5.59
- Beta
- 1.57
- Avg Volume
- 53.66K
Get TickerSpark's AI analysis on HBIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 20, 26 | Frost Mark T | other | 30,000 |
| Mar 16, 26 | Frost Mark T | buy | 5,000 |
| Mar 20, 26 | Duke John D | other | 75,000 |
| Mar 17, 26 | DENELSKY STEPHEN J | buy | 10,000 |
| Mar 17, 26 | Snider William | buy | 8,475 |
| Mar 16, 26 | Snider William | buy | 12,525 |
| Mar 16, 26 | Duke John D | buy | 5,000 |
| Dec 17, 25 | Snider William | other | 110,000 |
| Dec 17, 25 | Snider William | other | 600,000 |
| Sep 5, 25 | DENELSKY STEPHEN J | other | 110,000 |
Our HBIO Coverage
We haven't published any research on HBIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HBIO Report →